Hangzhou AGS MedTech Co., Ltd. (SHA:688581)
57.53
-0.59 (-1.02%)
At close: Mar 9, 2026
Hangzhou AGS MedTech Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Market Capitalization | 4,644 | 4,733 | 4,810 | 7,223 | - | - | Upgrade
|
| Market Cap Growth | -3.64% | -1.60% | -33.41% | - | - | - | Upgrade
|
| Enterprise Value | 2,905 | 2,994 | 2,723 | 5,252 | - | - | Upgrade
|
| Last Close Price | 57.53 | 58.63 | 58.43 | 85.62 | - | - | Upgrade
|
| PE Ratio | 20.77 | 21.24 | 16.39 | 33.25 | - | - | Upgrade
|
| Forward PE | 11.62 | 12.44 | 15.01 | - | - | - | Upgrade
|
| PS Ratio | 7.78 | 7.93 | 7.56 | 14.20 | - | - | Upgrade
|
| PB Ratio | 1.87 | 1.90 | 2.01 | 3.27 | - | - | Upgrade
|
| P/TBV Ratio | 1.88 | 1.92 | 2.02 | 3.30 | - | - | Upgrade
|
| P/FCF Ratio | - | - | 18.07 | 42.52 | - | - | Upgrade
|
| P/OCF Ratio | - | - | 15.23 | 32.62 | - | - | Upgrade
|
| EV/Sales Ratio | 4.87 | 5.01 | 4.28 | 10.32 | - | - | Upgrade
|
| EV/EBITDA Ratio | 10.65 | 10.98 | 9.39 | 23.31 | - | - | Upgrade
|
| EV/EBIT Ratio | 10.97 | 11.31 | 9.65 | 24.01 | - | - | Upgrade
|
| EV/FCF Ratio | - | - | 10.23 | 30.92 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | 0.02 | Upgrade
|
| Debt / FCF Ratio | - | - | 0.01 | 0.00 | 0.02 | 0.02 | Upgrade
|
| Net Debt / Equity Ratio | -0.70 | -0.70 | -0.74 | -0.92 | -0.70 | -0.75 | Upgrade
|
| Net Debt / EBITDA Ratio | -6.37 | -6.37 | -6.14 | -9.04 | -1.72 | -1.68 | Upgrade
|
| Net Debt / FCF Ratio | - | - | -6.69 | -11.99 | -2.77 | -1.98 | Upgrade
|
| Asset Turnover | - | - | 0.26 | 0.36 | 0.91 | 1.01 | Upgrade
|
| Inventory Turnover | - | - | 3.51 | 3.51 | 3.04 | 3.62 | Upgrade
|
| Quick Ratio | - | - | 12.91 | 17.37 | 3.18 | 3.19 | Upgrade
|
| Current Ratio | - | - | 13.34 | 17.78 | 3.65 | 3.81 | Upgrade
|
| Return on Equity (ROE) | 9.12% | 9.12% | 12.74% | 16.78% | 44.40% | 42.94% | Upgrade
|
| Return on Assets (ROA) | - | - | 7.22% | 9.75% | 23.02% | 24.30% | Upgrade
|
| Return on Invested Capital (ROIC) | 29.82% | 32.72% | 61.09% | 131.83% | 143.69% | 155.62% | Upgrade
|
| Return on Capital Employed (ROCE) | - | - | 11.70% | 9.90% | 39.30% | 42.90% | Upgrade
|
| Earnings Yield | 4.80% | 4.71% | 6.10% | 3.01% | - | - | Upgrade
|
| FCF Yield | - | - | 5.54% | 2.35% | - | - | Upgrade
|
| Dividend Yield | 2.36% | - | 2.35% | 1.21% | - | - | Upgrade
|
| Payout Ratio | - | - | 28.40% | 20.25% | 24.80% | 46.80% | Upgrade
|
| Buyback Yield / Dilution | 0.18% | 0.18% | -11.02% | -19.46% | 0.00% | - | Upgrade
|
| Total Shareholder Return | 2.55% | 0.18% | -8.67% | -18.25% | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.